Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1944
result was found. Results that relate to
R
Exploration of linear algebra teaching reform based on the training goal of high-end composite talents
Published on
Journal of Mathematical Medicine
2023,36(11):874-880.
6713 times
1635 times
Dong-Guo LI
Lei GAO
Wen-Xin ZHENG
Lin LI
Linea
r
algeb
r
a
Teaching
r
efo
r
m
Teaching model
Details
Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1388-1400.
7039 times
1434 times
Jian-Cheng ZHOU
Chun-Mei JI
Wen-Tong FANG
Ying ZOU
Yong-Qing WANG
Yuan-Yuan FU
Ali
r
ocumab
Hype
r
choleste
r
olemia
Safety
Efficacy
Cost-effectiveness
R
apid health technology assessment
Details
Analysis of anticoagulant therapy and pharmaceutical care for a patient with obstetrical antiphospholipid syndrome complicated with HELLP syndrome
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):218-223.
8029 times
2334 times
ZHU Yue
HUANG Xiaona
Obstet
r
ic antiphospholipid synd
r
ome
HELLP synd
r
ome
Anticoagulant the
r
apy
P
r
egnancy
Lactation
Pha
r
maceutical ca
r
e
Details
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1201-1208.
6597 times
1551 times
Xiao-Lan LIAO
Jia-Qi GE
Hai-Bin ZHU
Ting-Ting WU
Chun-Xia REN
Zi-Cheng YU
Vascula
r
endothelial g
r
owth facto
r
r
ecepto
r
-ty
r
osine kinase inhibito
r
s
Hype
r
tension
Adve
r
se d
r
ug events
Pha
r
macovigilance
FAE
R
S database
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1209-1216.
6187 times
1436 times
Ying-Chen ZHUO
Su-Ya ZHANG
Peng-Fei SONG
Wei-Yi FENG
Poly ADP-
r
ibose polyme
r
ase inhibito
r
Th
r
ombocytopenia
Ova
r
ian cance
r
Adve
r
se d
r
ug
r
eaction
Details
Practice and reflection of pharmacovigilance system construction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1217-1224.
7909 times
1909 times
Na WANG
Kang-Huai ZHANG
Pha
r
macovigilance
D
r
ug use safety
R
isk p
r
evention and cont
r
ol
Adve
r
se d
r
ug
r
eaction
Medication e
r
r
o
r
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1225-1230.
6517 times
1623 times
Ting-Ting ZHENG
Jin LI
Lu MAO
Ning CHEN
Wei ZHANG
Jian-Cun ZHEN
R
ational d
r
ug use
Abno
r
mal ea
r
ly wa
r
ning
Dynamic monito
r
ing
Clinical pha
r
macist
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1231-1237.
5588 times
1392 times
Lin TANG
Shan SHEN
Dong-Na ZOU
Bing LENG
Rui-Fang NIE
Yan JIN
Li-Kai LIN
Xian-Tao ZENG
Suo-Di ZHAI
Ling-Li ZHANG
Ning HOU
Polymyxins
Pediat
r
ic medication
Anti-infection
Guideline p
r
otocol
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1238-1242.
5975 times
1538 times
Hao-Chun TANG
Jun MENG
Zheng-Zheng XIA
Ling-Zhi REN
Non-small cell lung cance
r
Py
r
otinib
Adve
r
se d
r
ug
r
eaction
Safety
Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1243-1249.
6222 times
1594 times
An-Hua WEI
Wen-Jing LI
Yan HUANG
Dabigat
r
an etexilate
Potential d
r
ug-d
r
ug inte
r
actions
Safety
R
et
r
ospective study
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1259-1266.
6014 times
1549 times
Xi ZHAO
Xi YAN
Ning LI
Chun-Xia HOU
Abemaciclib
Fulvest
r
ant
Ho
r
mone
r
ecepto
r
-positive b
r
east cance
r
Ma
r
kov model
Cost-effectiveness analysis
Details
Optimization of extraction process of Coptidis Rhizoma-Scutellariae Radix based on BP-ANN and CCD-RSM in information entropy theory
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1267-1274.
5324 times
1317 times
Bao-Cai WANG
Jun-Jiang LI
Zhi-Wei XU
Coptidis
R
hizoma-Scutella
r
iae
R
adix
BP-ANN
CCD-
R
SM
Ext
r
action p
r
ocess
Info
r
mation ent
r
opy theo
r
y
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1275-1284.
6196 times
1474 times
Ya-Ping NIU
San-Bao CHAI
Jing-Zi MA
Meng ZHANG
Zuo-Xiang LIU
Shan-Shan WU
Feng SUN
Basal insulin
O
r
al hypoglycemic agents
Type 2 diabetes mellitus
Poo
r
t
r
eatment effect
Umb
r
ella
r
eview
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1285-1295.
5726 times
2014 times
Chao YE
Xin LI
Li-Hua LIU
Xin HE
Shen-Jue CHEN
Juan WANG
Tac
r
olimus
Acute panc
r
eatitis
Case
r
epo
r
t
Adve
r
se d
r
ug
r
eactions
Lite
r
atu
r
e analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):19-27.
7343 times
1935 times
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
D
r
ug benefit-
r
isk communication
Safety communication
D
r
ug safety info
r
mation
Pha
r
macovigilance
Details
上一页
1
2
34
35
36
37
38
39
40
129
130
下一页